Panbela Therapeutics (PBLA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Panbela Therapeutics, Inc. has announced its return to compliance with Nasdaq’s listing requirements regarding bid price and the number of publicly held shares. This milestone is critical for the company’s continued presence on the stock market, ensuring its shares meet the necessary standards for trading and ownership distribution.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.